A detailed history of Blackhill Capital Inc transactions in Baxter International Inc stock. As of the latest transaction made, Blackhill Capital Inc holds 5,000 shares of BAX stock, worth $194,549. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,000
Previous 5,000 -0.0%
Holding current value
$194,549
Previous $213,000 21.6%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$39.98 - $47.68 $523,737 - $624,608
-13,100 Reduced 72.38%
5,000 $227,000
Q4 2022

Feb 13, 2023

SELL
$49.7 - $57.71 $1.51 Million - $1.75 Million
-30,400 Reduced 62.68%
18,100 $922,000
Q4 2021

Feb 11, 2022

SELL
$74.57 - $87.19 $1.36 Million - $1.59 Million
-18,200 Reduced 27.29%
48,500 $4.16 Million
Q3 2021

Nov 12, 2021

SELL
$73.77 - $83.61 $3.5 Million - $3.97 Million
-47,500 Reduced 41.59%
66,700 $5.37 Million
Q1 2021

May 13, 2021

SELL
$76.38 - $86.03 $611,040 - $688,240
-8,000 Reduced 6.55%
114,200 $9.63 Million
Q3 2020

Nov 12, 2020

SELL
$78.33 - $90.73 $39,165 - $45,365
-500 Reduced 0.41%
122,200 $9.83 Million
Q1 2020

May 12, 2020

SELL
$71.57 - $93.3 $930,409 - $1.21 Million
-13,000 Reduced 9.58%
122,700 $9.96 Million
Q4 2019

Feb 10, 2020

SELL
$76.7 - $88.45 $95,875 - $110,562
-1,250 Reduced 0.91%
135,700 $11.3 Million
Q3 2019

Nov 07, 2019

SELL
$81.4 - $89.78 $130,240 - $143,648
-1,600 Reduced 1.15%
136,950 $12 Million
Q2 2018

Aug 06, 2018

SELL
$63.43 - $75.41 $282,263 - $335,574
-4,450 Reduced 3.11%
138,550 $10.2 Million
Q4 2017

Feb 05, 2018

BUY
$61.45 - $66.05 $61,450 - $66,050
1,000 Added 0.7%
143,000 $9.24 Million
Q3 2017

Nov 02, 2017

BUY
$59.5 - $64.61 $8.45 Million - $9.17 Million
142,000
142,000 $8.91 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $19.6B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Blackhill Capital Inc Portfolio

Follow Blackhill Capital Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blackhill Capital Inc, based on Form 13F filings with the SEC.

News

Stay updated on Blackhill Capital Inc with notifications on news.